HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $26 | -99.9% | 22 | -99.9% | 0.00% | – |
Q1 2023 | $51,391 | -97.9% | 34,034 | -96.6% | 0.00% | -100.0% |
Q4 2022 | $2,500,000 | -85.4% | 1,000,000 | -37.5% | 0.01% | -89.3% |
Q3 2021 | $17,109,000 | +352.9% | 1,600,486 | +557.4% | 0.08% | +341.2% |
Q2 2021 | $3,778,000 | +258.4% | 243,449 | +274.5% | 0.02% | +240.0% |
Q1 2021 | $1,054,000 | -54.9% | 65,000 | -41.1% | 0.01% | -54.5% |
Q4 2020 | $2,336,000 | -39.7% | 110,382 | -57.8% | 0.01% | -45.0% |
Q3 2020 | $3,873,000 | -8.8% | 261,341 | +50.5% | 0.02% | +5.3% |
Q1 2019 | $4,245,000 | +446.3% | 173,700 | +768.5% | 0.02% | +533.3% |
Q2 2018 | $777,000 | -61.2% | 20,000 | -85.0% | 0.00% | -72.7% |
Q1 2017 | $2,002,000 | +7314.8% | 133,483 | +12034.8% | 0.01% | – |
Q3 2015 | $27,000 | -99.7% | 1,100 | -99.6% | 0.00% | -100.0% |
Q2 2015 | $7,837,000 | +7.7% | 251,500 | -49.7% | 0.05% | +8.0% |
Q1 2015 | $7,275,000 | +41.8% | 500,000 | -2.0% | 0.05% | +38.9% |
Q4 2014 | $5,132,000 | – | 510,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 21,288 | $250,000 | 19.87% |
TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |